Document Detail

Kojic acid and its derivatives: history and present state of art.
MedLine Citation:
PMID:  15141965     Owner:  NLM     Status:  MEDLINE    
Kojic acid (5-hydroxy-2-hydroxymethyl-4-pyranone) represents an attractive polyfunctional skeleton for development of biologically active compounds. The authors prepared a great variety of kojic acid derivatives and selected biological properties have been studied. Thus, kojic acid derivatives are promising compounds that might advantageously be used in human and/or veterinary medicine and also in preparation of new, even more biologically active preparations.
J Brtko; L Rondahl; M Ficková; D Hudecová; V Eybl; M Uher
Related Documents :
8477005 - Chemical characterization and toxicity of dihydro derivatives of nodularin and microcys...
20112295 - An improved procedure for the synthesis of dehydroamino acids and dehydropeptides from ...
8514635 - Synthesis and antimicrobial activity of sperabillin derivatives.
23860655 - Purification of prostatic acid phosphatase (pap) for structural and functional studies.
18284035 - Pretreatment with a mixture of essential fatty acids protects rats from anxiogenic effe...
4008485 - Neutral and acidic species of human intestinal mucin. evidence for different core pepti...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Central European journal of public health     Volume:  12 Suppl     ISSN:  1210-7778     ISO Abbreviation:  Cent. Eur. J. Public Health     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2004-05-14     Completed Date:  2004-09-16     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9417324     Medline TA:  Cent Eur J Public Health     Country:  Czech Republic    
Other Details:
Languages:  eng     Pagination:  S16-8     Citation Subset:  IM    
Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antifungal Agents / chemical synthesis*,  pharmacology
Antineoplastic Agents / chemical synthesis*,  pharmacology
Leukemia L1210 / drug therapy
Pyrones / chemistry*,  pharmacology*
Reg. No./Substance:
0/Antifungal Agents; 0/Antineoplastic Agents; 0/Pyrones; 501-30-4/kojic acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Possible genotoxic risk of combined exposure to pharmaceutical coal tar and UV-B radiation.
Next Document:  Protection of newborn organism against effect of oxidative stress.